VBI Vaccines Inc/BC Quarterly Interest Expense in USD from Q1 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
VBI Vaccines Inc/BC quarterly/annual Interest Expense history and growth rate from Q1 2016 to Q1 2024.
  • VBI Vaccines Inc/BC Interest Expense for the quarter ending March 31, 2024 was $1.82M, a 27.2% increase year-over-year.
  • VBI Vaccines Inc/BC Interest Expense for the twelve months ending March 31, 2024 was $6.79M, a 51% increase year-over-year.
  • VBI Vaccines Inc/BC annual Interest Expense for 2023 was $6.4M, a 59.7% increase from 2022.
  • VBI Vaccines Inc/BC annual Interest Expense for 2022 was $4.01M, a 15.3% decline from 2021.
  • VBI Vaccines Inc/BC annual Interest Expense for 2021 was $4.73M, a 74.7% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $6.79M $1.82M +$389K +27.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $6.4M $1.72M +$513K +42.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 $5.89M $1.54M +$585K +61.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $5.3M $1.71M +$807K +89.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $4.5M $1.43M +$489K +52% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $4.01M $1.21M +$159K +15.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 $3.85M $958K -$68K -6.63% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $3.92M $901K +$56K +6.63% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $3.86M $940K -$872K -48.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $4.73M $1.05M +$347K +49.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-13
Q3 2021 $4.39M $1.03M +$284K +38.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $4.1M $845K +$163K +23.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $3.94M $1.81M +$1.23M +211% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $2.71M $702K +$178K +34% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-07
Q3 2020 $2.53M $742K +$116K +18.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $2.41M $682K +$116K +20.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 $2.3M $582K +$102K +21.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $2.2M $524K -$137K -20.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 $2.33M $626K -$90K -12.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $2.42M $566K -$150K -21% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $2.57M $480K -$59K -10.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $2.63M $661K -$32K -4.62% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 $2.66M $716K -$26K -3.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $2.69M $716K -$27K -3.63% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-06
Q1 2018 $2.72M $539K -$165K -23.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $2.88M $693K +$335K +93.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-25
Q3 2017 $2.55M $742K +$804K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $1.74M $743K +$740K +24667% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-26
Q1 2017 $1M $704K +$679K +2716% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $324K $358K Oct 1, 2016 Dec 31, 2016 10-K 2017-03-20
Q3 2016 -$62K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $3K Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-31
Q1 2016 $25K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.